ArticleCureus2026
Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Coagulation testing in the laboratory is performed at 37°C. However, this in vitro testing may not reflect the in vivo pathophysiology affecting coagulation factors in clinical conditions that cause hyperthermia. This study aimed to evaluate the effect of hyperthermia on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (APTT). Methodology This cross-sectional analytical study was conducted in a teaching hospital in North India over a period of one and a half years. In total, 50 patients aged >18 years were randomly selected from the samples received for coagulation testing in the laboratory. PT and APTT were determined by the standard manual tilt tube method within four hours of collection. For PT, uniplastin 5 (ISI-1.1), and for APTT, Liquicelin-E (Tulip diagnostics) was used. PT and APTT were determined at three different hyperthermic temperatures (39°C, 41°C, and 43°C). Testing at the standard 37°C was also performed. Parametric data were reported as mean and standard deviation, while non-parametric data were reported as median and interquartile range. The variation in PT/INR and APTT results at four designated temperatures was analyzed by repeated-measures analysis of variance. Statistical analysis was performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). Results Mean PT at 39°C, 41°C, and 43°C was 16.0 ± 7.1 seconds, 17.2 ± 9.6 seconds, and 19.7 ± 14.4 seconds, respectively. Mean PT at 37°C was 15.1 ± 4.9 seconds. The difference was statistically significant (p = 0.001). Mean INR at 37°C, 39°C, 41°C, and 43°C was 1.2 ± 0.4, 1.3 ± 0.6, 1.4 ± 0.9, and 1.6 ±1.4, respectively. The rising trend with increasing temperatures was significant (p = 0.004). Mean APTT at 37°C, 39°C, 41°C, and 43°C was 30.3 ± 11.6 seconds, 32.6 ± 11.5 seconds, 36.2 ± 13.2 seconds, and 42.5 ± 14.7 seconds, respectively. The difference was statistically significant (p < 0.001). Conclusions This study showed significant prolongation of PT, INR, and APTT at hyperthermic temperatures. The degree of prolongation of clotting times was greater in patients on oral anticoagulant therapy and those with liver disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.